Brief Report
VARIAR Study: Assessment of Short-term Efficacy and Safety of Rituximab Compared to an Tumor Necrosis Factor Alpha Antagonists as Second-line Drug Therapy in Patients With Rheumatoid Arthritis Refractory to a First Tumor Necrosis Factor Alpha Antagonist
Estudio VARIAR: VAloración de la eficacia y seguridad a corto plazo en artritis reumatoide del uso de RItuximab comparado con Antagonistas del factor de necrosis tumoral alfa en segunda línea terapéutica en pacientes con artritis reumatoide Refractarios a un primer antagonista del factor de necrosis tumoral alfa
Vicenç Torrente-Segarraa,
, Asunción Acosta Pereirab, Rosa Morlac, José Miguel Ruizd, Teresa Clavaguerae, Ramon Figulsa, Hector Corominasa, Carme Gelib, Rosa Rosellóf, Juan José de Agustíng, Cayetano Alegreg, Carolina Pérezh, Angel Garcíai, Arturo Rodríguez de la Sernab
Corresponding author
a Hospital General Hospitalet-Moisès Broggi, Sant Joan Despí, Barcelona, Spain
b Hospital Santa Creu i Sant Pau, Barcelona, Spain
c Hospital del Vendrell, El Vendrell, Tarragona, Spain
d Hospital de Viladecans, Viladecans, Barcelona, Spain
e Hospital de Palamós, Palamós, Girona, Spain
f Hospital de San Jorge, Huesca, Spain
g Hospital de la Vall d’Hebron, Barcelona, Spain
h Hospital de Mollet, Mollet del Vallès, Barcelona, Spain
i Hospital de Torrevieja, Torrevieja, Alicante, Spain
Ver másRead
5246
Timeswas read the article
2048
Total PDF
3198
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 November | 62 | 46 | 108 |
| 2024 October | 71 | 38 | 109 |
| 2024 September | 67 | 14 | 81 |
| 2024 August | 80 | 34 | 114 |
| 2024 July | 52 | 29 | 81 |
| 2024 June | 54 | 24 | 78 |
| 2024 May | 47 | 25 | 72 |
| 2024 April | 40 | 23 | 63 |
| 2024 March | 35 | 18 | 53 |
| 2024 February | 30 | 16 | 46 |
| 2024 January | 28 | 15 | 43 |
| 2023 December | 32 | 28 | 60 |
| 2023 November | 41 | 14 | 55 |
| 2023 October | 45 | 33 | 78 |
| 2023 September | 86 | 40 | 126 |
| 2023 August | 31 | 12 | 43 |
| 2023 July | 32 | 24 | 56 |
| 2023 June | 36 | 24 | 60 |
| 2023 May | 55 | 22 | 77 |
| 2023 April | 37 | 11 | 48 |
| 2023 March | 80 | 30 | 110 |
| 2023 February | 70 | 31 | 101 |
| 2023 January | 30 | 13 | 43 |
| 2022 December | 81 | 43 | 124 |
| 2022 November | 52 | 23 | 75 |
| 2022 October | 76 | 30 | 106 |
| 2022 September | 24 | 38 | 62 |
| 2022 August | 33 | 35 | 68 |
| 2022 July | 35 | 34 | 69 |
| 2022 June | 44 | 29 | 73 |
| 2022 May | 44 | 41 | 85 |
| 2022 April | 43 | 38 | 81 |
| 2022 March | 45 | 32 | 77 |
| 2022 February | 22 | 20 | 42 |
| 2022 January | 33 | 36 | 69 |
| 2021 December | 34 | 44 | 78 |
| 2021 November | 42 | 33 | 75 |
| 2021 October | 70 | 58 | 128 |
| 2021 September | 42 | 53 | 95 |
| 2021 August | 39 | 35 | 74 |
| 2021 July | 22 | 67 | 89 |
| 2021 June | 47 | 28 | 75 |
| 2021 May | 43 | 44 | 87 |
| 2021 April | 79 | 97 | 176 |
| 2021 March | 38 | 24 | 62 |
| 2021 February | 33 | 25 | 58 |
| 2021 January | 27 | 27 | 54 |
| 2020 December | 39 | 24 | 63 |
| 2020 November | 33 | 15 | 48 |
| 2020 October | 23 | 24 | 47 |
| 2020 September | 38 | 27 | 65 |
| 2020 August | 26 | 20 | 46 |
| 2020 July | 18 | 30 | 48 |
| 2020 June | 37 | 19 | 56 |
| 2020 May | 40 | 11 | 51 |
| 2020 April | 28 | 24 | 52 |
| 2020 March | 17 | 5 | 22 |
| 2020 February | 1 | 0 | 1 |
| 2018 December | 2 | 0 | 2 |
| 2018 May | 4 | 1 | 5 |
| 2018 April | 41 | 9 | 50 |
| 2018 March | 118 | 12 | 130 |
| 2018 February | 24 | 8 | 32 |
| 2018 January | 16 | 3 | 19 |
| 2017 December | 31 | 9 | 40 |
| 2017 November | 27 | 10 | 37 |
| 2017 October | 31 | 7 | 38 |
| 2017 September | 26 | 10 | 36 |
| 2017 August | 28 | 14 | 42 |
| 2017 July | 41 | 20 | 61 |
| 2017 June | 40 | 19 | 59 |
| 2017 May | 43 | 24 | 67 |
| 2017 April | 30 | 17 | 47 |
| 2017 March | 32 | 41 | 73 |
| 2017 February | 17 | 13 | 30 |
| 2017 January | 54 | 39 | 93 |
| 2016 December | 58 | 47 | 105 |
| 2016 November | 41 | 43 | 84 |
| 2016 October | 5 | 5 | 10 |
Show all
